当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2012年第35期 > 正文
编号:12352860
抑癌基因p14ARF对慢性粒细胞白血病细胞增殖、细胞周期及凋亡的影响机制研究(3)
http://www.100md.com 2012年12月15日 刘静 白元松 李云
第1页

    参见附件。

     [8] Bai Y,Soda Y,Izawa K,et al. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector [J]. Gene Ther,2003,10(17):1446-1457.

    [9] Le Frere-Belda MA,Gil Diez de Medina S,Daher A, et al. Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status [J]. Hum Pathol, 2004,35(7):817-824.

    [10] Kang MY,Lee BB,Ji YI,et al. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer [J]. Cancer,2008,112(8):1699-1707.

    [11] Rizos H,Scurr LL,Irvine M,et al. p14ARF regulates E2F-1 ubiquitination and degradation via a p53-dependent mechanism [J]. Cell Cycle, 2007,6(14):1741-1747.

    [12] Schmitt CA,Mc Currach ME,De Stanchina E,et al. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53 [J]. Genes Dev,1999,13(20):2670–2677.

    [13] 毕丹,周淑芸,曾木圣,等.慢性粒细胞白血病p53基因功能检测[J].癌症,1999,18(4):404-417.

    (收稿日期:2012-07-04 本文编辑:冯 婕)

    

您现在查看是摘要介绍页,详见PDF附件(2602kb)